-
09.22.2020 | Debiopharm honored as a 2020 Swiss biotech success story winner for outstanding achievements over 40 Years
Every year, the Swiss Biotech Association awards companies or individuals within the biotech sector in Switzerland in recognition of specific success factors.
-
08.24.2020 | FDA grants HelixBind breakthrough device designation for RaPID sepsis test
HelixBind announced today it has been awarded the Breakthrough Device Designation from the FDA for RaPID/BSI, the first test for its RaPID platform.
Toggle navigation